There is no commercial support for this activity.

About the speaker

Mark Ilgen is a clinical psychologist and a health services researcher with an interest in improving outcomes for individuals with problematic alcohol or drug use. He is currently a Research Career Scientist in the Department of Veterans Affairs (VA) Center for Clinical Management Research in Ann Arbor, Michigan and a Professor in the Department of Psychiatry at the University of Michigan. A core focus of Mark's work has been on understanding the relationship between pain and substance use. This research involves developing and testing psychosocial interventions to improve functioning in adults with chronic pain and substance use disorders. In addition, he has studied substance use as a risk factor for suicide and unintentional overdose. In his role as the Director of the University of Michigan Addiction Treatment Services (UMATS), he has worked to structure addiction services at the University of Michigan to be accessible and appealing to a wide range of patients and based on current research.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she  has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Mark A. Ilgen, PhD, reports his research is supported with grants from the National Institutes of Health and Veteran Affairs Research Services and is an owner of Arborsense. He will not discuss any products, services, or off-label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on December 4, 2023. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.